somalux.org
Home
About
Programs & Impact
Donate
Contact
Shop
Sciences & Sources
somalux.org
Home
About
Programs & Impact
Donate
Contact
Shop
Sciences & Sources
More
  • Home
  • About
  • Programs & Impact
  • Donate
  • Contact
  • Shop
  • Sciences & Sources
  • Sign In
  • Create Account

  • Orders
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Orders
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About
  • Programs & Impact
  • Donate
  • Contact
  • Shop
  • Sciences & Sources

Account

  • Orders
  • My Account
  • Sign out

  • Sign In
  • Orders
  • My Account

Sciences & Sources

Somalux shares evidence-based education on photobiomodulation (PBM/LLLT) and related wellness modalities. This page lists selected public sources we use when we describe mechanisms (e.g., mitochondria/ATP, nitric oxide signaling) and when we reference device regulatory listings (e.g., FDA 510(k) clearances).


Note: Somalux does not diagnose, treat, or cure disease. Information is educational and intended to support informed conversations with licensed clinicians.


Many PBM/LLLT devices are regulated as Class II medical devices and may be “510(k) cleared” (marketing clearance), which is different from “FDA approval.” (FDA Access Data)

Sciences & Sources

FDA (official) – 510(k) database and examples
- FDA 510(k) Premarket Notification search/result example (Erchonia SHL, K142042):
 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K142042
- FDA 510(k) decision summary PDF (Erchonia EVRL, K191257):
 https://www.accessdata.fda.gov/cdrh_docs/pdf19/K191257.pdf
- FDA 510(k) decision summary PDF (Erchonia XLR8, K211186):
 https://www.accessdata.fda.gov/cdrh_docs/pdf21/K211186.pdf
- FDA 510(k) decision summary PDF (Erchonia FX-405, K212595):
 https://www.accessdata.fda.gov/cdrh_docs/pdf21/K212595.pdf
- FDA 510(k) decision summary PDF (Erchonia FX 635, K190572):
 https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190572.pdf
Erchonia (vendor statements – cite as “Erchonia states…”)
- “We own 22 of the 25 FDA-clearances given to Low-Level Lasers…” (Erchonia EMEA page):
 https://erchonia-emea.com/low-level-laser-therapy-devices/
PBM mechanisms – mitochondria / cytochrome c oxidase / nitric oxide (open access where possible)
- “Light, Cytochrome C Oxidase, and Nitric Oxide—Review…” (PMC full text):
 https://pmc.ncbi.nlm.nih.gov/articles/PMC7495914/
- “Nitric oxide and a novel function of mitochondrial cytochrome c oxidase…” (PubMed):
 https://pubmed.ncbi.nlm.nih.gov/21356170/
- “Photobiomodulation and nitric oxide signaling” (PMC full text):
 https://pmc.ncbi.nlm.nih.gov/articles/PMC9808891/
- “Irradiance-dependent changes… nitric oxide… cytochrome c oxidase hypothesis” (PubMed):
 https://pubmed.ncbi.nlm.nih.gov/32790251/



Brain PBM / network studies (optional but strong for “neuronal modulation” wording)
- “Transcranial photobiomodulation-induced changes in human brain networks…” (PMC full text):
 https://pmc.ncbi.nlm.nih.gov/articles/PMC7587286/
- 2025 MEG/EEG connectivity paper (Frontiers full text):
 https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2025.1704482/full
- 2023 review “Transcranial photobiomodulation with near-infrared light”:
https://journals.lww.com/nrronline/fulltext/2023/09000/transcranial_photobiomodulation_with_near_infrared.15.aspx


Copyright © 2026 somalux.org - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept